Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is a progressively debilitating neurodegenerative disease characterized by α-synucleinopathy, which involves all districts of the brain-gut axis, including the central, autonomic and enteric nervous systems. The highly bidirectional communication between the brain and the gut is markedly influenced by the microbiome through integrated immunological, neuroendocrine and neurological processes. The gut microbiota and its relevant metabolites interact with the host via a series of biochemical and functional inputs, thereby affecting host homeostasis and health. Indeed, a dysregulated microbiota-gut-brain axis in PD might lie at the basis of gastrointestinal dysfunctions which predominantly emerge many years prior to the diagnosis, corroborating the theory that the pathological process is spread from the gut to the brain. Toll-like receptors (TLRs) play a crucial role in innate immunity by recognizing conserved motifs primarily found in microorganisms and a dysregulation in their signaling may be implicated in α-synucleinopathy, such as PD. An overstimulation of the innate immune system due to gut dysbiosis and/or small intestinal bacterial overgrowth, together with higher intestinal barrier permeability, may provoke local and systemic inflammation as well as enteric neuroglial activation, ultimately triggering the development of alpha-synuclein pathology. In this review, we provide the current knowledge regarding the relationship between the microbiota-gut–brain axis and TLRs in PD. A better understanding of the dialogue sustained by the microbiota-gut-brain axis and innate immunity via TLR signaling should bring interesting insights in the pathophysiology of PD and provide novel dietary and/or therapeutic measures aimed at shaping the gut microbiota composition, improving the intestinal epithelial barrier function and balancing the innate immune response in PD patients, in order to influence the early phases of the following neurodegenerative cascade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Systemic inflammation induced by intestinal inflammation and barrier disruption is key in gut–brain communication [57,58,59].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [59]
In the citing paper
“Gut dysbiosis and the consequent development of pathogenic populations within the gut microbiota, may contribute to a wide variety of pathologies, even in sites distant from the gut, ranging from bowel inflammation, to neurodegenerative diseases (including Parkinson’s disease) and cancer [43,49,50].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Haddadi, R., Nayebi, A. M., & Brooshghalan, S. E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.020 · Cited by 39
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Cited by
Items 301–350 of 350
Interrelationship between Gut microbiota and Parkinson’s disease
Shivananjappa, M. M., Manasa, R., Prakruthi, M., & Shekhara Naik, R. (2020) · IP Journal of Nutrition Metabolism and Health Science · doi:10.18231/j.ijnmhs.2020.015
Gut microbiota and brain function and pathophysiology
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00014-1
Probiyotiklerin Akne Vulgaris’e Etkisi
Gündüz, N., & İrkin, R. (2022) · Sağlık Akademisi Kastamonu · doi:10.25279/sak.899794
Atualização sobre o uso de probióticos no tratamento de doenças neurológicas
Cavalcante, M. M., & de Souza, I. L. L. (2021) · Revista Saúde e Desenvolvimento · Cited by 2
Peer Review #1 of "Altered gut microbiota associated with symptom severity in schizophrenia (v0.1)"
(2020) · PeerJ · doi:10.7287/peerj.9574v0.1/reviews/1
“…neuropsychiatric disorders PeerJ reviewing PDF | (2020:02:46023:1:2:NEW 8 Jun 2020) 82 including bipolar disorder(Hu et al. 2019), major depression disorder(Zheng et al. 2016), 83 Alzheimer’s disease(Cattaneo et al. 2017), Parkinson’s disease(Caputi & Giron 2018), and 84 autism(Tomova et al. 2015).”
GUT-MICROBIOME-BRAIN AXIS AND ITS INFLUENCE ON PARKINSON'S DISEASE (Review Article)
SAJI, J. S., SHARON, S., TRINITA, R., SAFAR, B., KAVIL, K. I., & Akhvlediani, T. (2022) · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA · doi:10.52340/jecm.2022.02.19
The Gut Microbiome Was Associated With Brain Structure and Function in SchizophreniaPreprint
Li, S., Song, J., Ke, P., Kong, L., Lei, B., Zhou, J., Huang, Y., Li, H., Li, G., Chen, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-181659/v1
Review of prodromal symptoms in Parkinson's Disease detected by MRI, EEG And microbiomePreprint
Echeverri, I. C., de la Iglesia-Vayá, M., Molina‐Mateo, J., de Mejía, F. R., & Giraldo, B. S. (2019) · Frenxiv (OSF Preprints) · doi:10.31226/osf.io/yfnmw
Microbiota: ¿Sabemos de qué estamos hablando?
Eriutina, N. A. (2021) · Archivos de coloproctología · doi:10.26754/ojs_arcol/archcolo.202146350 · Cited by 1
Pathogenetic Mechanisms of the Relationship Between Osteoarthritis and Intestinal Dysbiosis
Poryadin, G. V., Захватов, А. Н., Zakharkin, I. A., Parshina, A., & Shaev, A. A. (2023) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2023-13-5-325-334 · Cited by 1
Gonçalves, I. D. O., da Silva, P. R. R., Vieira, L. F. M., Maia, M. G. F., Barroso, J. M. D. C., Prado, M. E. O., dos Santos, J. A., & Tavares, P. G. B. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n4-050
ANAIS DA XXIX SEMANA DE BIOMEDICINA: SAÚDE E DESENVOLVIMENTO
Fontes, A., Mendonça, A. A., de Melo, A. M. M. A., Soares, A. L. B., Bento, B. M., de Oliveira, C. M. F., Santos, D. D. S., Pereira, D. R., Milani, D. R. D. C., de Melo, F. P. T., et al. (2023) · doi:10.47094/978-65-6036-344-1
O eixo microbiota-intestino-cérebro na doença de Parkinson: revisão integrativa
Mafra, H. T., & de Souza, J. P. P. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n4-011 · Cited by 1
Introduction to Gut Microbiota and their Effects on Various Brain Disorders
Usmani, A., & Mishra, A. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010008
Os benefícios do uso de probióticos como tratamento adjuvante na doença de Alzheimer
Nunes, F. A. S., & Sobral, M. L. P. (2024) · Revista de Medicina · doi:10.11606/issn.1679-9836.v103i4e-218868
Dairy consumption and the risk of Parkinson's disease
Hasan, R. S., & Forsan, H. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00010-5 · Cited by 1
“Pseudoneurotransmission” and gut microbiome – brain communication in neuropsychiatric disorders
Liapis, C. C. (2024) · Psychiatriki · doi:10.22365/jpsych.2024.024
Crosstalk between gut-brain axis and brain components along with associated neurological disorders
Bindal, P., Kaushal, S., Singh, C., & Singh, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00005-5
谭, 林. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.41016
Razdan, A., Mishra, M. K., & Pandey, R. P. (2025) · Springer eBooks · doi:10.1007/978-981-96-6246-3_7
Regulated cell death and inflammaging in neurodegenerative disorders
Liu, H., Wen, S., Gao, X., Wu, C., Lai, B., Zhu, J., & Kong, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32852-7.00009-7 · Cited by 2
Parkinson disease among patients with diabetes mellitus
Ghoben, M. K., & Shimmary, B. H. A. (2025) · International Journal of Advanced Research in Medicine · doi:10.22271/27069567.2025.v7.i3b.658
Gut Microbiota, Formaldehyde Dysmetabolism, and Cognitive Impairment
Liu, K., He, Y., Wen, B., Yan, W., & He, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-7281-3_7
Zhao, Z., Ning, J., 鲍秀琦, Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Figshare · doi:10.6084/m9.figshare.17030693
Zhao, Z., Ning, J., 鲍秀琦, Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Figshare · doi:10.6084/m9.figshare.17030702
Yang, C., Feng, Z., Deng, H., Dai, L., He, L., Yin, L., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.21594075
Yang, C., Feng, Z., Deng, H., Dai, L., He, L., Yin, L., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.21594078
Zhao, Z., Ning, J., 鲍秀琦, Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Figshare · doi:10.6084/m9.figshare.17030708
Yang, C., Feng, Z., Deng, H., Dai, L., He, L., Yin, L., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.21594072
Understanding the role of Toll signalling in Drosophila midgut stem cell proliferation.
Udayakumar, A. (2023) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-2aryymm6k
Yang, C., Feng, Z., Deng, H., Dai, L., He, L., Yin, L., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.21594081
Yang, C., Feng, Z., Deng, H., Dai, L., He, L., Yin, L., & Zhao, J. (2022) · Figshare · doi:10.6084/m9.figshare.21594084
Shtanova, L. Y., Veselsky, S. P., Yanchuk, P. I., Rozhnova, R. A., Moskvina, V. S., Shablykina, O. V., Reshetnik, E. M., Kravchenko, О. V., & Khilya, V. P. (2025) · Fìzìologìčnij žurnal · doi:10.15407/fz71.04.029
D-mannose alleviates rotenone-induced PD mouse model through microbiota-gut-brain axis
Hong, Y., Ge, C., Jin, J., Gao, Y., & Tang, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-36272-0
Shen, Y., Wang, Z., Cheng, X., Tang, F., Rao, S., & Zhang, D. (2026) · Medicine · doi:10.1097/md.0000000000048338
“…may provide added benefits, including reduced bloating, enhanced quality of life, and even modulation of disease progression in conditions like PD. [58–60] Looking forward, research should emphasize large-scale, strain-specific and dose-response studies, direct head-to-head comparisons with…”
Human microbiomes in neurodegenerative diseases: an overview of their potential involvement
Borrego-Ruiz, A., & Borrego, J. J. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004153
Influence of non-sugar sweeteners on neural health: The current state of knowledge
Olaseni, A. A., Weis, G. C. C., Maurer, L. H., Adedara, I. A., & Emanuelli, T. (2026) · Advances in neurotoxicology · doi:10.1016/bs.ant.2026.02.002
Sabouri, E., Shahmoradi, T., Keshvari, N. Z., khodaee, P., Saleki, K., & Rezaei, N. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2026-0064
“Previous studies have highlighted the role of gut microbiota composition in promoting neuroin fl ammation that contributes to neuronal loss in PD, in which TLRs have a considerable role (Caputi and Giron 2018; Chen et al. 2023; El fi l et al. 2020; Greco et al. 2019; Sampson et al. 2016).”
Hu, Y., Chen, J.-S., Zhou, M., Huang, H., Zhou, Y.-F., Zhou, H.-Y., & Lv, Z. (2026) · Infectious Diseases of Poverty · doi:10.1186/s40249-026-01436-7
Luo, J., Li, X., Liu, B., Yu, Y., Shen, X., Liu, H., Hu, S., Luo, Q., Liang, X., Xiong, Y., et al. (2026) · Nutrients · doi:10.3390/nu18203371
“LPS activates TLR-associated pathways, inducing neuroinflammation and oxidative stress and impairing neuronal function [72].”
The Microbiota-Gut-Brain Axis in Neurological and Neuropsychiatric Disorders: A Literature Review
Brar, H., Do, N., Kelser, C., Pattipati, S. N., & Nalamolu, K. R. (2026) · Cureus · doi:10.7759/cureus.118684
Probiotics and oncology: Unlocking their potential for cancer treatment
Rana, R., Malothra, A., Kattel, K., Lalhlenmawia, H., Azizov, S., & Kumar, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45154-6.00002-7
Nouar, A., Viau, C., Dutta, S., Pang, Z., & Xia, J. (2026) · Metabolites · doi:10.3390/metabo16110851
Noor, U., Khan, I., Khan, I., Kong, Y., Khan, S. H., & Li, S. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-06013-1
Metadata
- Authors
- Caputi, V., & Giron, M. C.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Giron, Maria Cecilia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-06-06
- Volume
- 19
- Issue
- 6
- Pages
- 1689
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6032048
- OpenAlex
- W2807153072
- Cited by
- 338
- References
- 140
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 57 · 2021: 69 · 2020: 43 · 2019: 29 · 2018: 8
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Università degli Studi di Padova (PRID Grant 2017, Assegno di Ricerca 2016)
- San Camillo Hospital, Treviso (Italy) (Grant 2015)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, microbiota-gut-brain axis, Toll-like receptors, synucleinopathies, gut dysbiosis, small intestinal bacterial overgrowth, intestinal permeability, innate immunity, neuroinflammation, gastrointestinal dysfunction, gut microbiota metabolites
- MeSH terms
- Gastrointestinal Microbiome, Animals, Anti-Bacterial Agents, Brain, Humans, Immunity, Innate, Parkinson Disease, Probiotics, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.